Search

Your search keyword '"Welters, Marij J P"' showing total 252 results

Search Constraints

Start Over You searched for: Author "Welters, Marij J P" Remove constraint Author: "Welters, Marij J P"
252 results on '"Welters, Marij J P"'

Search Results

5. Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment

8. Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer

9. Actively personalized vaccination trial for newly diagnosed glioblastoma

11. HPV16 E7 DNA tattooing: safety, immunogenicity, and clinical response in patients with HPV-positive vulvar intraepithelial neoplasia

13. The common HLA class I-restricted tumor-infiltrating T cell response in HPV16-induced cancer

17. Intradermal vaccination of HPV-16 E6 synthetic peptides conjugated to an optimized Toll-like receptor 2 ligand shows safety and potent T cell immunogenicity in patients with HPV-16 positive (pre-)malignant lesions

18. Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry

22. Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma

24. Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses

27. Tumor-specific T cells support chemokine-driven spatial organization of intratumoral immune microaggregates needed for long survival

28. Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8+ T cells with detection by ELISPOT and HLA-multimer staining

29. The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study

30. CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumors

31. Predictive Biomarkers for Outcomes of Immune Checkpoint Inhibitors (ICIs) in Melanoma: A Systematic Review

35. PROTECT: Prospective Phase-II-Trial Evaluating Adaptive Proton Therapy for Cervical Cancer to Reduce the Impact on Morbidity and the Immune System

37. A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions

45. Photochemical Internalization Enhanced Vaccination Is Safe, and Gives Promising Cellular Immune Responses to an HPV Peptide-Based Vaccine in a Phase I Clinical Study in Healthy Volunteers

47. Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancer

48. Strong vaccine responses during chemotherapy are associated with prolonged cancer survival

49. Actively personalized vaccination trial for newly diagnosed glioblastoma

Catalog

Books, media, physical & digital resources